could make developing guidelines more expensive and result in guidelines that are more complex hindering translation into practice. 4, 5 Others argue for reconsideration of involvement of patients in the process as evidence to support improvement in the quality of the guidelines through patient participation does not exist. 6 Other concerns relate to the perceived meaningfulness and importance of patient contributions. In their knowledge synthesis, Legare et al. 1 note that there is often a distinction between the technical, knowledge based aspects of the guideline development assumed by the researchers, and the values and preferences aspects assumed by the patients. Some suggest Spring 2016 • vol 10.1 that patient involvement be more targeted and used at strategic decision points. 7 It is not only a matter of when in the process that patient involvement would be most meaningful; there is the form of the involvement or how the patient is involved.
Decisions of when and how patients should be involved in guideline development are complex and depend on the content area. Patient participation may be most important in areas where there is little or no evidence. 3 Rehabilitation in the context of HIV is an evolving area of practice as HIV transitions from an acute fatal illness to a chronic illness in which people living with HIV with access to medications live longer with episodic periods of wellness and illness. This increased longevity is accompanied by common comorbidities related to aging, the virus, and antiretroviral medications.
Rehabilitation can be defined broadly as any services or providers with the aim to reduce impairments, activity limitations or social participation restrictions experienced by an individual. 8 As with many emerging areas of practice, developing evidence-based guidelines related to HIV and rehabilitation is challenging because high levels of evidence, such as systematic reviews and meta-analyses on effectiveness of interventions are largely absent. In previous work, we conducted interviews and focus groups with 28 stakeholders in the field of HIV and rehabilitation and developed recommendations for the process of developing CPGs in this area. 9 Recommendations stated that HIV rehabilitation practice guidelines should be flexible, strike a balance between a broad and a specific scope, take on a variety of formats for different end users, be interprofessional, and have clear strategies for knowledge translation. 9 Additionally, recognizing the lack of high-quality research, stakeholders suggested that the term "evidence-informed recommendations"
would be preferable to CPGs.
Objectives
We developed evidence-informed recommendations for rehabilitation with older adults aging with HIV using a community-engaged approach. 10 ing between recommendations that nearly all patients will accept and those that may vary depending on patient choice.
This was a necessity in our process given the low levels of evidence; we believe this was a strength of our approach. We offer the following lessons learned from our experiences to be considered by researchers working with community members to develop evidence-informed recommendations.
1. Provide time to develop as a team and to discuss and understand the roles, perspectives, biases, and expertise of each member. Although logistically many of the meetings were held by teleconference, face-to-face meetings were important to establish a sense of team connectivity and to promote robust discussion. Team members were mindful of their role in providing their perspectives and values and prompted considerable debate throughout the process. The team should discuss at the beginning of the process and revisit throughout whether the community member is expected to represent a constituency and/or bring personal experience to the table. 15 The PHAs on our team had prior research experience and knowledge of HIV and rehabilitation and hence also contributed to the methodological discussions. Although we believe this was a strength, others argue that highly experienced community representatives become fellow academics and thus are not representative of the general community perspective and experiences. 6 2. Engage PHAs in initial research discussions to determine how and when involvement would be most meaningful and comfortable. The development of evidence-informed recommendations is a comprehensive and often onerous task. Early discussions among our team determined that it would be most efficient for research staff to do the initial data extraction and critical appraisal of the articles, tasks that did not necessarily require the knowledge related to patient values and preferences that PHAs on the team could provide. Although some advocate participation of patients through all phases of guideline development this may not be practical, feasible or affordable. 6 Intensive community participation in guideline development can be costly requiring significant time investment from both researchers and community members. 6 One challenge for community members on our team related to other commitments in the form of employment or otherwise, which meant they had limited time to devote their expertise to this project. This was compounded by the complexities of the project which extended our deadlines and resulted in a longer time commitment than expected. Nevertheless, our process of community input from both internal team members and through external endorsement is a way to include diverse perspectives without resorting to a large internal team, which may increase costs and complexity and hamper decision making. 16 3. Be mindful that engaging in research may trigger stress and anxiety among community members. In our team, the activity of reviewing a vast amount of literature on comorbidities, disability, and aging with HIV was raised as anxiety provoking for PHAs who themselves were aging with HIV. This highlights the importance of carefully considering the nature and extent of community engagement when it comes to guideline development, the potential risks of involvement and the need to provide support for dealing with discomforting findings. In this situation, it is critical to incorporate strategies to provide support to empower PHAs to remain engaged in research. While we were unable to find other literature that refers to anxiety created through involvement in the guideline development process our experiences highlight the need for researchers to be mindful of this possibility especially in vulnerable populations. Aging with HIV is a relatively recent phenomenon fraught with uncertainty, 17 which may highlight vulnerabilities in this population. 4 . Because it is difficult to anticipate areas in which there may be controversy in research and, specifically, development of practice recommendations, we recommend developing terms of reference and decision-making processes for all teams, including those with previous experience working together. In our study, PHAs on the team were knowledgeable and well-versed in HIV and rehabilitation research and had a history of working with the researchers. We did not experience process-related issues; differences of opinion were resolved by consensus. However, challenges could arise if community members have varying levels of expertise and opposing views when trying to decide on inclusion of evidence, or the exclusion of certain recommendations. Developing terms of reference can help to formalize the structure of partnership and clarify roles and expectations among researchers and community members. 18 Although we did not develop terms of reference or a formalized process for resolving conflict, we believe this is important in early stages of team formation. Pagliari et al. 16 go further by suggesting that methods used to achieve consensus should be reported by guideline developers to allow users to assess the potential influence of group process on the validity of the decision-making process.
5. Allow opportunities for training and mentoring for those who want to develop skills in research. As noted, our team benefited through the contributions of PHAs to all components of the research in addition to providing their personal values and preferences throughout the process. Although the literature often makes a distinction between the methodological expertise provided by the researchers and patients' values and preferences, we do not see these as discreet entities. We believe that, to best reflect Meaningful Involvement of People Living with HIV, researchers need to be open to varied contributions and provide ongoing opportunities and support for skill development. Capacity building can also occur in academic researchers. In our instance, researchers and PHAs on the team had the opportunity to develop collaborations over the years through the leadership of CWGHR. This resulted in a strong foundational partnership enabling us to successfully develop the recommendations. This relationship has been mutually beneficial, allowing academic researchers and the community to learn how to effectively work together in a complex and multi-staged process of evidence-informed recommendations development.
6. Build in a formal evaluation of the recommendation (or guideline) development process and the PHAs' level of satisfaction with their involvement. We support calls for more rigorous evaluation of the "value added" of community involvement in guideline development. 16 The goal of incorporating patients' preferences in the guideline development process varies considerably. Boivin et al. 19 note that there are fundamental differences between social perspectives that seek to maximize population health benefits, those that promote individual tailored approaches, and those that promote involvement for political legitimacy. Future work needs to be clear about the rationale for community participation to ensure that the appropriate outcome measures are chosen to evaluate the effectiveness of patient their involvement.
It is important to note that involvement of the PHAs was also a form of integrated knowledge translation to help ensure that the recommendations are most relevant and applicable to all relevant stakeholders and knowledge users. The involvement of the CWGHR as a key knowledge user on the project was an important strategy to ensure translation to clinicians, PHAs, and community organizations. Next steps include the development of fact sheets targeted to these groups to translate the recommendations into practice. Although not part of this project, PHAs will remain integrally involved and take a leadership role in this process.
These lessons build on the work of others who promote the use of more than one method of patient involvement in guideline development. 3 We believe these lessons learned and subsequent recommendations are of broad interest to all researchers wishing to incorporate community perspectives meaningfully into guideline development. Award.
